Jane Wasman

Affiliations

  • Director at Sellas Life Sciences Group Inc. (SLS), 2025-06-02
  • at Rigel Pharmaceuticals Inc (RIGL), 2025-05-28
  • Director at Athersys Inc / New (ATHX), 2023-01-11
  • President, Intl And Gc at Acorda Therapeutics Inc (ACOR), 2019-12-04
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
SLS $1.69 20,000 $33,800.00 30,400 2025-05-30 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
ACOR $1.60 2,227 $3,552.73 117,420 2019-12-02 Filing
ACOR $20.52 3,067 $62,947.41 105,287 2018-12-03 Filing
ACOR $28.63 350 $10,020.01 102,110 2018-01-19 Filing
ACOR $27.58 34,170 $942,299.26 102,460 2018-01-19 Filing
ACOR $20.52 4,564 $93,662.41 102,110 2017-12-01 Filing